Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis.
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance.
[Neuromyelitis optica and anti-aquaporin 4 antibody].
Long-Term Data of Efficacy, Safety and Tolerability in a Real Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.
Interferon-β1b Increases Th2 Response in Neuromyelitis Optica.
Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Multiple Sclerosis and Amyotrophic Lateral Sclerosis: Finding and then Losing an Association.
Visual evoked potentials in early diagnosis of demyelinating diseases - a case report of Devic's disease.
Aging and multiple sclerosis.
Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6.
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Detection of reduced interhemispheric cortical communication during task execution in multiple sclerosis patients using functional near-infrared spectroscopy.
Origin and differentiation of microglia.
Role of microglia in CNS autoimmunity.
Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: Biochemical, pharmacological and toxicological implications.
ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis.
Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.
[Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature.]
On the sex ratio of multiple sclerosis.
Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran.
Pages
« first
‹ previous
…
207
208
209
210
211
212
213
214
215
…
next ›
last »